Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
about
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Outcomes of Measurable Residua ...... Wilms Tumor 1 Gene Expression
@en
type
label
Outcomes of Measurable Residua ...... Wilms Tumor 1 Gene Expression
@en
prefLabel
Outcomes of Measurable Residua ...... Wilms Tumor 1 Gene Expression
@en
P2093
P1476
Outcomes of Measurable Residua ...... Wilms Tumor 1 Gene Expression
@en
P2093
Albert Kheradpour
Aleksandra Petrovic
Alexandra Cheerva
Alexia Adams
Alfred P Gillio
Allen R Chen
Amy Keating
Andrew Harris
Ann E Haight
Barbara J Bambach
P304
P356
10.1016/J.BBMT.2018.06.010
P577
2018-06-19T00:00:00Z